Publications by authors named "Mika Stepankiw"

Claim this Profile
E
Evaluation of everolimus in renal cell cancer.
Robert Amato, Mika Stepankiw

Expert Opin Pharmacother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer.
Robert Amato, Mika Stepankiw, Patricia Gonzales

Cancer Chemother Pharmacol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial assessing granulocyte-macrophage-colony stimulating factor, ketoconazole plus mitoxantrone in metastatic castration-resistant prostate cancer progressing after docetaxel treatments.
Robert J Amato, Somyata Saxena, Mika Stepankiw

Cancer Invest· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer.
Robert J Amato, Mika Stepankiw

Clin Med Insights Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of everolimus plus sorafenib for patients with advanced renal cell cancer.
Robert J Amato, Amber L Flaherty, Mika Stepankiw

Clin Genitourin Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of MVA-5T4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer.
Robert J Amato, Mika Stepankiw

Future Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis